Clinical trial
Prognostic Power of the VEXUS Score in Septic Shock: Efficacy in Mortality Prediction
NCT07124741 is registered in ClinicalTrials.gov with Antalya Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Power of the VEXUS Score in Septic Shock: Efficacy in Mortality Prediction
- Lead sponsor
- Antalya Training and Research Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 30, 2026
- Completion date
- December 20, 2026
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock, vexus